Twist’s New Gold Standard in Antibody Discovery

Twist Biopharma and Abveris have joined forces to deliver an industry-leading, end-to-end antibody discovery solution that leverages comprehensive in vivo, in vitro, and in silico antibody discovery and engineering services. The combination of streamlined workflows can enable not only expedited timelines, but also can drive success against diverse therapeutic targets including challenging

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Twist’s New Gold Standard in Antibody Discovery

Related Resources

Finding Improved Biologics with Twist’s Machine Learning and Deep Learning Tools

Twist Bioscience: High Throughput Antibody Expression Service

Optimizing a Candidate Therapeutic Antibody to Optimize Pharmacokinetics using Informed Library Design